CCO Expert Recap
CCO Expert Recap of data from the 2004 International AIDS Conference
Source: 2004 International AIDS Conference*
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Part 1: Antiretroviral Therapy: Current Regimens, Novel Strategies, Resistance, and New Agents
Program Director: John P. Phair, MD
 
- Joseph J. Eron, Jr., MD
- Daniel R. Kuritzkes, MD
- David J. Back, PhD
|
 
- Richard E. Chaisson, MD
- Judith S. Currier, MD, MSc
- Courtney V. Fletcher, PharmD
|
 
- Joel E. Gallant, MD, MPH
- W. David Hardy, MD
- Donald P. Kotler, MD
|
 
- William A. O'Brien, MD, MS
- Andrew T. Pavia, MD
- Bruce Polsky, MD
|
 
- William G. Powderly, MD
- Kathleen E. Squires, MD
- Andrew R. Zolopa, MD
|
|
|
 Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the results of recent studies of FDA-approved antiretroviral agents
Discuss the latest findings from studies of investigational antiretrovirals and treatment strategies
Review new data on HIV drug resistance and its clinical implications
|
Slideset
CCO Slideset – Part 1: Antiretroviral Therapy: Current Regimens, Novel Strategies, Resistance, and New Agents
 |
|

CCO’s slides summarizing important new data presented at medical conferences, printed in journal articles, or those used by speakers in live programs (satellites, dinner meetings, or Webcasts) are made available to members free of charge to download for use in their own talks.
Format: Microsoft PowerPoint (.ppt) | File size: 1,188 KB
|
|
Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|